FTXH vs. XLVI
FTXH (First Trust Nasdaq Pharmaceuticals ETF) and XLVI (State Street Health Care Select Sector SPDR Premium Income ETF) are both exchange-traded funds - FTXH is a Health & Biotech Equities fund tracking the Nasdaq U.S. Smart Pharmaceuticals Index, while XLVI is a Derivative Income fund actively managed by State Street. FTXH is passively managed, while XLVI is actively managed. Over the past year, FTXH returned 49.44% vs 22.96% for XLVI. Their correlation of 0.83 means they have usually moved in the same direction. FTXH charges 0.60%/yr vs 0.35%/yr for XLVI.
Performance
FTXH vs. XLVI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FTXH achieves a 17.64% return, which is significantly higher than XLVI's 6.89% return.
FTXH
- 1D
- -0.77%
- 1M
- -1.43%
- 6M
- 12.69%
- YTD
- 17.64%
- 1Y
- 49.44%
- 3Y*
- 15.53%
- 5Y*
- 9.04%
- 10Y*
- —
- ALL TIME*
- 8.02%
XLVI
- 1D
- -0.20%
- 1M
- 0.97%
- 6M
- 6.00%
- YTD
- 6.89%
- 1Y
- 22.96%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 19.93%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $132.42M | $64.10M | $22.26M | |
| $940.40K | $699.80K | $484.44K |
FTXH vs. XLVI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 17.64% | 24.83% |
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | 6.89% | 12.41% |
Correlation
The correlation between FTXH and XLVI is 0.83, meaning they have usually moved in the same direction, including during past declines.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.83 |
Correlation (All Time) Calculated using the full available price history since Jul 30, 2025 | 0.83 |
The correlation between FTXH and XLVI has been stable across timeframes, ranging from 0.83 to 0.83 - a consistent structural relationship.
FTXH vs. XLVI - Sectors Allocation Comparison
Sectors
FTXH
XLVI
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
FTXH
XLVI
Basic Materials
FTXH
-
XLVI
-
Communication Services
FTXH
-
XLVI
-
Consumer Cyclical
FTXH
-
XLVI
-
Consumer Defensive
FTXH
-
XLVI
-
Energy
FTXH
-
XLVI
-
Financial Services
FTXH
-
XLVI
Industrials
FTXH
-
XLVI
-
Real Estate
FTXH
-
XLVI
-
Technology
FTXH
-
XLVI
-
Utilities
FTXH
-
XLVI
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FTXH vs. XLVI — Risk / Return Rank
FTXH
XLVI
FTXH vs. XLVI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FTXH | XLVI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.77 | ||
| Sortino ratioReturn per unit of downside risk | +1.06 | ||
| Omega ratioGain probability vs. loss probability | 1.48 | 1.41 | +0.08 |
| Calmar ratioReturn relative to maximum drawdown | 6.65 | 2.83 | +3.82 |
| Martin ratioReturn relative to average drawdown | 19.78 | 8.00 | +11.78 |
Loading charts...
Drawdowns
FTXH vs. XLVI - Drawdown Comparison
The maximum FTXH drawdown since its inception was -32.11%, which is greater than XLVI's maximum drawdown of -8.14%. Use the drawdown chart below to compare losses from any high point for FTXH and XLVI.
Loading charts...
Drawdown Indicators
| FTXH | XLVI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -32.11% | -8.14% | -23.97% |
Max Drawdown (1Y)Largest decline over 1 year | -7.47% | -8.14% | +0.67% |
Max Drawdown (3Y)Largest decline over 3 years | -19.51% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -19.51% | — | — |
Current DrawdownCurrent decline from peak | -2.77% | -1.66% | -1.11% |
Average DrawdownAverage peak-to-trough decline | -5.76% | -1.78% | -3.98% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.51% | 2.88% | -0.37% |
Volatility
FTXH vs. XLVI - Volatility Comparison
First Trust Nasdaq Pharmaceuticals ETF (FTXH) has a higher volatility of 4.91% compared to State Street Health Care Select Sector SPDR Premium Income ETF (XLVI) at 3.36%. This indicates that FTXH's price experiences larger fluctuations and is considered to be riskier than XLVI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FTXH | XLVI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.91% | 3.36% | +1.55% |
Volatility (6M)Calculated over the trailing 6-month period | 12.81% | 8.73% | +4.08% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.04% | 10.75% | +6.29% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.53% | 11.04% | +5.49% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.43% | 11.04% | +7.39% |
FTXH vs. XLVI - Expense Ratio Comparison
FTXH has a 0.60% expense ratio, which is higher than XLVI's 0.35% expense ratio.
Dividends
FTXH vs. XLVI - Dividend Comparison
FTXH's dividend yield for the trailing twelve months is around 1.10%, less than XLVI's 12.76% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 1.10% | 1.41% | 1.66% | 1.55% | 1.11% | 1.03% | 0.82% | 0.67% | 0.91% | 2.18% | 0.19% |
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | 12.76% | 5.73% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
FTXH and XLVI have a correlation of 0.83, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FTXH has higher volatility (4.91%) compared to XLVI (3.36%). In terms of maximum drawdown, FTXH dropped -32.11% vs XLVI's -8.14%.
On 1-year performance, FTXH leads with 49.44% vs 22.96% for XLVI. On fees, XLVI is cheaper at 0.35% per year. On volatility, XLVI has been the lower-risk option at 3.36%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, FTXH has performed better with a 49.44% return vs 22.96%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XLVI is cheaper with a 0.35% expense ratio, compared with 0.60% for FTXH.
XLVI has the higher dividend yield at 12.76%, compared with 1.10% for FTXH.
FTXH is categorized as Health & Biotech Equities, while XLVI is Derivative Income. They also come from different issuers: First Trust and State Street. Their fees differ too: 0.60% for FTXH and 0.35% for XLVI.
FTXH currently has the higher Sharpe Ratio (2.92 vs 2.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FTXH and XLVI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer